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The Type II Secretion System and Its Ubiquitous Lipoprotein
Substrate, SslE, Are Required for Biofilm Formation and Virulence of
Enteropathogenic Escherichia coli
Deborah L. Baldi,a Ellen E. Higginson,a Dianna M. Hocking,a Judyta Praszkier,a* Rosalia Cavaliere,b Catherine E. James,b
Vicki Bennett-Wood,a Kristy I. Azzopardi,a,c Lynne Turnbull,b Trevor Lithgow,d Roy M. Robins-Browne,a,c Cynthia B. Whitchurch,b and
Marija Tauscheka
Department of Microbiology and Immunology, The University of Melbourne, Melbourne, Australiaa; the ithree institute, University of Technology Sydney, Broadway,
Australiab; Murdoch Childrens Research Institute, Royal Children’s Hospital, Parkville, Australiac; and Department of Biochemistry and Molecular Biology, Monash
University, Melbourne, Australiad
Enteropathogenic Escherichia coli (EPEC) is a major cause of diarrhea in infants in developing countries. We have identified a
functional type II secretion system (T2SS) in EPEC that is homologous to the pathway responsible for the secretion of heat-labile
enterotoxin by enterotoxigenic E. coli. The wild-type EPEC T2SS was able to secrete a heat-labile enterotoxin reporter, but an
isogenic T2SSmutant could not. We showed that the major substrate of the T2SS in EPEC is SslE, an outer membrane lipopro-
tein (formerly known as YghJ), and that a functional T2SS is essential for biofilm formation by EPEC. T2SS and SslE mutants
were arrested at the microcolony stage of biofilm formation, suggesting that the T2SS is involved in the development of mature
biofilms and that SslE is a dominant effector of biofilm development. Moreover, the T2SS was required for virulence, as infection
of rabbits with a rabbit-specific EPEC strain carrying a mutation in either the T2SS or SslE resulted in significantly reduced in-
testinal colonization andmilder disease.
The type II secretion system (T2SS) is a multimeric proteintranslocase used by pathogenic Gram-negative bacteria to se-
crete virulence determinants. These virulence determinants are
commonly toxins, such as cholera toxin ofVibrio cholerae (59) and
the heat-labile toxin (LT) of enterotoxigenic Escherichia coli
(ETEC) (61). Alternatively, the virulence determinants are degra-
dative enzymes such as elastase and phospholipase C from Pseu-
domonas aeruginosa (6). Proteins destined to be secreted by the
T2SS are first translocated across the cytoplasmic membrane via
either the Sec or Tat machinery (52, 66), then folded and assem-
bled in the periplasm, and finally secreted across the outer mem-
brane by the T2SS itself.
The multimeric type II secretion apparatus is composed of at
least 12 subunits, all of which are required for activity (34, 58). The
complex spans the periplasm and consists of an outer membrane
pore (48), a platform of proteins associated with the inner mem-
brane that provide the energy to drive secretion (53), and a set of
proteins that assemble into a pilus-like structure (the pseudopi-
lus) in the periplasm (65).
In E. coli, three distinct T2SSs have been identified. A plasmid-
encoded T2SSEDL933 in an enterohemorrhagic E. coli (EHEC)
strain, EDL933, secretes StcE, a protease that cleaves complement
components (39). The T2SSEDL933 also contributes to EHEC ad-
herence and intestinal colonization (31). A second system,
T2SSK-12 in E. coli K-12 strain MC4100, is nonfunctional under
standard culture conditions but secretes endogenous chitinase
when derepressed (24). The third system, T2SSH10407, identified
by us in ETEC strainH10407, is responsible for the secretion of LT
(61). The T2SSH10407 is highly conserved, as homologs are present
in other E. coli pathotypes including EHEC, enteropathogenic E.
coli (EPEC), enteroaggregative E. coli (EAEC), enteroinvasive E.
coli (EIEC), and extraintestinal E. coli (ExPEC) (9, 13, 14, 32, 33,
38, 49, 63). Remnants of T2SSH10407 are also present in the E. coli
K-12 strains MG1655 and W3110 (54, 61, 63).
To characterize the T2SSH10407, we investigated this system in
the prototypical human EPEC strain, E2348/69. EPEC is a leading
cause of infantile diarrhea in developing countries (55) but, unlike
ETEC, does not appear to secrete an enterotoxin (41, 56). The
major virulence determinant of EPEC is an 35.6-kb chromo-
somal pathogenicity island, termed the locus of enterocyte efface-
ment (LEE). The LEE encodes a type III protein secretory system,
at least nine type III secreted proteins (e.g., EspB, -F, and -G), and
an outer membrane adhesin (intimin) encoded by the eae gene
(19, 21, 32), all of which are required to produce distinctive at-
taching and effacing lesions in the intestinal epithelium that char-
acterize infection with EPEC (25).
Characterization of the T2SSH10407 of E2348/69 showed that
this system is functional, that it secretes a lipoprotein, SslE, for
secreted and surface-associated lipoprotein from E. coli (formerly
YghJ [32, 67]). Both SslE and T2SS mutants were attenuated for
biofilm formation. Importantly, T2SSH10407 and SslEmutants of a
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rabbit-specific EPEC (REPEC) strain, E22, showed a reduced abil-
ity to colonize the intestine and to cause disease in a rabbit model
of infection. Our results demonstrate that the T2SSH10407 and its
substrate SslE are critical virulence determinants of EPEC. As this
type II secretion complex and SslE are highly conserved, they may
also contribute to the virulence of other pathogenic E. coli strains.
MATERIALS AND METHODS
Bacterial strains, plasmidgrowthconditions, andprimers.Thebacterial
strains and plasmids used in this study are listed in Table 1. Strains were
propagated in Luria-Bertani (LB) or Casamino Acids-yeast extract-salts
(CAYE) medium (23, 57) at 37°C with shaking (225 rpm) unless other-
wise noted. The primers used in the construction of plasmids andmutants
are listed in Table 2.
Construction of nonpolar gspD, gspK, and sslE mutants. The dele-
tionmutation in the gene encoding the essential type II pseudopilin, gspK,
was constructed in E2348/69 and E22 by allelic exchange with gspK::Kanr,
amplified from E. coli strain MT2 using Platinum Taq DNA polymerase
(Promega) and primers P5 and P12. These exchanges were facilitated by
the  Red recombinase system carried on plasmid pKD46 (18). Deletion
mutations in gspD and sslE of E2348/69 and E22 were constructed using
the “gene-gorging” technique (29). Phusion high-fidelity DNA polymer-
ase (New England BioLabs) was used to amplify the FLP recombination
target (FRT)-flanked Kanr gene from pKD4 (using primers pKD4F and
pKD4R) and 0.5 kb of DNA flanking the target genes (using primer
pairs gspD.ISceIF/gspD.KmR or sslE.ISceIF/sslE.KmR for the upstream
flanks and gspD.ISceIR/gspD.KmFor sslE.ISceIR/sslE.KmF for the down-
stream flanks) from the genomic DNA. The Kanr fragment was joined to
the appropriate upstream and downstream fragments by overlapping ex-
tension PCR (11) using Platinum TaqDNA polymerase and primer pairs
gspD.ISceIF/gspD.ISceIR or sslE.ISceIF/sslE.ISceIR. The ISceI-flanked
PCR products were cloned into pGEM-T Easy to yield the donor plasmids
required for gene gorging. The allelic exchange of the wild-type chromo-
somal gene with the Kanr-disrupted gene was facilitated by the  Red
recombinase system carried on plasmid pACBSR (29). When required,
the Kanr gene was excised using the flanking FRT sites and FLP helper
plasmids pCP20 (18) and pFT-A (51). All mutations were confirmed by
PCR analysis, using primers flanking the targeted regions.
Construction of trans-complementing plasmids. pJP52 and pJP51,
the gspD complementing plasmids, were generated by amplifying
2,151-bp fragments containing gspD from E2348/69 and from E22
genomic DNA, respectively, using primers gspD.F and gspD.R, digesting
the DNA with BamHI/SalI, and ligating it to BamHI/SalI-digested
pACYC184. pJP49, the gspK-complementing plasmid, was generated by
amplifying a 1,057-bp fragment containing gspK fromE22 genomicDNA,
using primers gspK.F and gspK.R, digesting the DNA with BamHI/SalI,
TABLE 1 Strains and plasmids used in this study
Strain or plasmid Relevant characteristicsa Source or reference
Strains
E22 REPEC serotype O103:H2, Rifr 42
E22gspD E22 gspD, Rifr This study
E22gspK E22 gspK::Kanr, Rifr This study
E22sslE E22 sslE, Rifr This study
E2348/69 EPEC serotype O127:H6 40
E2348/69gspD E2348/69 gspD This study
E2348/69gspK E2348/69 gspK::Kanr This study
E2348/69sslE E2348/69 sslE This study
H10407 ETEC serotype 078:H11, LT, ST 22
MC4100 F araD139 (argF-lac)U169 rpsL150 relA1 flbB5301 deoC1 ptsF25 rbsR thiA 10
MT2 H10407 gspK::Kanr 61
Plasmids
pACBSR Medium-copy-no. vector, p15A ori, Cmr 29
pACYC184 Medium-copy-no. vector, p15A ori, Cmr, Tcr 12
pBAD24 Medium-copy-no. vector, ori pMB1, Apr 26
pBR322 Medium-copy-no. vector, ori pMB1, Apr, Tcr 8
pCP20 Low-copy-no. vector, ori R101, repA101ts, flp, Apr, Cmr 18
pFT-A Low-copy-no. vector, ori R101 repA101ts, flp, Apr 51
pGEM-T Easy High-copy-no. vector, ori pMB1, Apr Promega
pJP15 sslEE2348/69 in pSU39, Kan
r This study
pJP16 sslEE22 in pSU39, Kan
r This study
pJP33 hltA promoter and hltB from H10407 in pBR322, Apr This study
pJP49 gspKE22 in pACYC184, Cm
r This study
pJP51 gspDE22 in pACYC184, Cm
r This study
pJP52 gspDE2348/69 in pACYC184, Cm
r This study
pJP115 micA promoter from E2348/69 in pMU6400, Tpr This study
pJP168 PBAD promoter and araC replaced by PtetA and tetR gene from Tn10 in pBAD24, Ap
r This study
pJP169 sslEE2348/69-tetraCys in pJP168, Ap
r This study
pJP183 pBR322 with the promoter and NH terminus of the Tcr gene deleted, Apr This study
pKD4 FRT-flanked Kanr gene, Kanr, Apr 18
pKD46 Low-copy-no. vector, ori R101, repA101ts, PBAD- Red, Ap
r 18
pMU2386 Single-copy-no. translational fusion vector, Tpr 5
pMU6400 Synthetic RBS with ATG start codon fused in phase with codon 8 of lacZ in pMU2386, Tpr This study
pSU39 Medium-copy-no. vector, p15A ori, Kanr 7
a Apr, ampicillin resistance; Cmr, chloramphenicol resistance; Kanr, kanamycin resistance; Rifr, rifampin resistance; Tcr, tetracycline resistance; Tpr, trimethoprim resistance.
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and ligating it to BamHI/SalI-digested pACYC184. pJP15 was generated
by amplifying a 5,251-bp fragment containing the sslE gene from
E2348/69 genomic DNA using primers E2348sslE.F and E2348sslE.R, di-
gesting the DNA with HindIII/XbaI, and ligating it to HindIII/XbaI-di-
gested pSU39. pJP16 was generated by amplifying a 5,143-bp fragment
containing sslE from E22 genomic DNA using primer pair E22sslE.F/
E22sslE.R, digesting the DNA with BamHI/EcoRI, and ligating it to
BamHI/EcoRI-digested pSU39. Phusion high-fidelity DNA polymerase
was used in all these amplification reactions.
Construction of LTB expression vector. Overlapping PCR was used
to generate a 793-bp fragment containing the hltA promoter upstream of
the hltB gene. Platinum TaqDNA polymerase and primers YJ001 and TR,
which incorporate a BamHI site and an overhang region complementary
to htlB, respectively, were used to amplify a 213-bp fragment encompass-
ing the hltA promoter (68) from H10407 genomic DNA. A 595-bp frag-
ment containing hltB was amplified from H10407 genomic DNA using
primers TOXB3= and TF, which incorporate a BamHI site and a 5= over-
hang region complementary to the hltA promoter, respectively. The two
PCR products were joined using Vent polymerase (New England Bio-
Labs) and primers YJ001 and TOXB3=, and the resultant 793-bp fragment
was cloned into the BamHI site of pJP183 to generate plasmid pJP33.
Construction of plasmid expressing SslE-tetraCys. pJP168, a tetra-
cycline-inducible gene expression vector, was generated by replacing the
ClaI-NheI fragment of pBAD24 carrying araC-PBAD with a 769-bp
ClaI-NheI fragment containing tetR-PTetA of Tn10, amplified frompFT-A
using primers TetRA.F and TetRA.R. Overlapping PCR was used to gen-
erate a 4,640-bp fragment containing the coding sequence of sslE-tetraCys
flanked by NcoI/HindIII restriction endonuclease sites. This involved
joining a 4,574-bp fragment containing the sslE coding sequence, ampli-
fied from E2348/69 genomic DNA using primers SslEtct.Fs and SslE.R1,
to primer SslEtct.R, using Phusion high-fidelity DNA polymerase and
primers SslEtct.Fs and SslEtct.Rs. The sslE-tetraCys fragment was inserted
into the NcoI/HindIII site of pJP168, generating plasmid pJP169.
Construction of the lacZ fusion plasmids. The transcriptional lacZ
fusion vector pMU6400 was constructed by ligation of annealed primers
2386lT4/2386lB4 to HindIII/BamHI-digested pMU2386, so that the ATG
start codon of the ribosome binding site (RBS) encoded by these oligonu-
cleotides was in phase with the lacZ coding sequence. The micA-lacZ fu-
sion plasmid, pJP115, was constructed by ligating the promoter region of
micA, amplified from E2348/69 genomic DNA using primers micA.F and
micA.R, to HindIII/XbaI-digested pMU6400.
Assay for LTB. The GM1 ganglioside enzyme-linked immunosorbent
assay (ELISA) used to assay LTB was performed as described previously
(61).
Protein identification. Edman degradation of SslE was performed by
the Australian Proteomic Analysis Facility, North Ryde, Australia. Tan-
dem mass spectrometry was performed at the Bio21 Institute, The Uni-
versity of Melbourne, Australia.
Visualization of SslE. The procedure used to visualize tetraCys-
tagged SslE with the biarsenical dye Lumio Green was performed accord-
TABLE 2 Primers used in this study
Primer Sequence 5= to 3=
2386lB4 GATCCGTCATAGTTGTGTTTCCTGTTCATCTAGTTATCTAGAGCTAGATCTAGGA
2386lT4 AGCTTCCTAGATCTAGCTCTAGATAACTAGATGAACAGGAAACACAACTATGACG
E22sslE.F ACAGAATTCGCCAGCGTTATCGGCGTTATC
E22sslE.R ACAGGATCCGTGAACGCCTTATCCGGCATAC
E2348sslE.F TCATCTAGAGCCAGCGTTATCGGCATTATCAC
E2348sslE.R ACTAACCTTGAACGCCTTATCCGGCCTA
gspD.F AGAGGATTCGCGCTAACCGCATTTAATCCAG
gspD.ISceIF TAGGGATAACAGGGTAATCACTGATCCACGAGCAATGATTGC
gspD.ISceIR TAGGGATAACAGGGTAATAGACCGCATTCAGCCGCTGTTC
gspD.KmF CTAAGGAGGATATTCATATGGTGACCATTCTGCGTGACGGTATGG
gspD.KmR GAAGCAGCTCCAGCCTACACACCCCTGTGCTTCCAGCAGGTTAAG
gspD.R AGAGTCGACAACTGTAGGGCAGACGCACG
gspK.F AGAGGATCCTTGAACGCATCTGGTTGTTACGC
gspK.R AGAGTCGACGATCAGCGGCGCAAAGC
micA.F GACAAGCTTCGAACACGGTGATTGCGTCG
micA.R GACTCTAGACTCTGAATTCAGGGATGATGATAAC
P5 GCAGCAGGTGACTAACGGC
P12 CAGGGCTTAACCACGGGTC
pKD4F TGTGTAGGCTGGAGCTGCTTC
pKD4R CATATGAATATCCTCCTTAG
TetRA.F GACTAGATCGATCTTGGTTACCGTGAAGTTACCATC
TetRA.R CACGCTAGCATTCATTTCACTTTTCTCTATCACTGATAGG
TF CAGTCAGAGGTTGACATATATAACAG
TOXB3= GCGGATCCTAGCTTAGTTTTTTCTGTGTG
TR GTCAACCTCTGACTGCATACAAGAAG
sslE.ISceIF TAGGGATAACAGGGTAATCGGATGATCGTTAATATCATCCGGC
sslE.ISceIR TAGGGATAACAGGGTAATAATCCTCCGACGGTTGCCAG
sslE.KmF CTAAGGAGGATATTCATATGGTGGCGGACACGCTGATGCTGTG
sslE.KmR GAAGCAGCTCCAGCCTACACAGCCATCACAACCGGCTAACAGG
SslEtct.Fs TATCCATGGATAAGAAATTTAAATATAAGAAATCGC
SslEtct.R GTGAAGCTTTTAACGGCCGCCCGGTTCCATGCAGCAGCCCGGGCAGCAGTTCAGAAAGCTGCCCGCTTCGGCTGGC
ATCGAATACTCGG
SslE.R1 TTCGGCTGGCATCGAATACTC
SslEtct.Rs GTGAAGCTTTTAACGGCCGCC
YJ001 TTTGGATCCTAATCAGGTTGCCATGATTC
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ing to the directions of the manufacturer (Invitrogen) with the following
changes: Opti-MEM was replaced with phosphate-buffered saline (PBS),
and the Lumio labeling reagent contained 5 mM dithiothreitol (DTT).
Bacteria were fixed in 1.6% paraformaldehyde prior to labeling and
mounted on poly-L-lysine slides using Dako fluorescence mounting me-
dium.
Proteinase K shaving. Cells from 1-ml aliquots of bacterial culture
were harvested by centrifugation at 3,000  g for 3 min at 4°C. Bacteria
were washed with 20 mM Tris-HCl, pH 8, and resuspended in 600 l of
the same solution. Polymyxin B and/or proteinase K were added to final
concentrations of 2.0 and 0.02 mg/ml, respectively. Samples containing
polymyxin B or proteinase K were incubated on ice for 10 and 30 min,
respectively, and 10 l of treated bacterial cells was processed by SDS-
PAGE.
-Galactosidase assays. -Galactosidase activity was determined by
the method of Miller as described previously (44, 62).
Biofilm flow cell cultivation. Biofilms were cultivated at 37°C in
three-channel flow cells with individual channel dimensions of 1 by 4 by
40 mm (BioCentrum-DTU). A plastic coverslip (ibidi GmbH) was at-
tached to the flow cell with silicon glue and used as substratum for biofilm
growth. Bacteria were cultured overnight in LB, diluted 1:100 in 37°C
Dulbecco’s modified Eagle’s medium (DMEM), and inoculated into each
channel. After 1 h flow was recommenced and maintained at 451 l/min
for 96 h using a peristaltic pump. At various time points to 96 h, samples
were fixed with 4% paraformaldehyde and stained with Syto9 (Invitro-
gen) to allow visualization.
Microscopy and image analysis of biofilms. Microscopic image ac-
quisition of biofilms was performed utilizing confocal laser scanning mi-
croscopy on a Nikon A1R-A1 inverted microscope. Simulated 3-dimen-
sional (3D) fluorescence blend images of individual panels were generated
using the Imaris software package (Bitplane AG). For COMSTAT quan-
tification of biofilm growth (30), each strain was grown in a single chan-
nel, and image stacks were acquired from equivalent areas of the flow
channel where the flow of medium was calculated to be laminar.
Infection of rabbits. For in vivo assays of virulence, 4- to 5-week-old
New Zealand White rabbits were inoculated with either a wild-type
REPEC strain, E22, or an isogenicmutant. Rabbits wereweighed daily and
examined for clinical signs of illness including weight loss and evidence of
diarrhea as described previously (2). Fecal shedding of the infecting
strains was determined by culture of rectal swabs on MacConkey agar
supplemented with rifampin (50 g/ml) to distinguish them from the
rabbits’ microbiota. Animals were euthanized when they lost greater than
15% body weight or demonstrated severe diarrhea. Segments from the
distal small intestine were obtained from animals within each experimen-
tal group and fixed in 2.5% gluteraldehyde, postfixed in 2.5% osmium
tetroxide for 1 h, dehydrated through a graded acetone series, and embed-
ded in Epon-Araldite epoxy resin. Thin sections were cut and stainedwith
10% uranyl acetate and 2.5% lead citrate before being viewed under a
Phillips CM10 electron microscope at 80 kV.
FAS and adherence assays.Fluorescence actin staining (FAS)was per-
formed as described previously (36) using a 3-h incubation period with
the following changes: HEp-2 cells were incubated with 50g/ml phalloi-
din conjugated to tetramethyl rhodamine isocyanate (TRITC; Sigma) for
30 min. To detect adherent bacteria, DAPI (4=,6-diamidino-2-phenylin-
dole; Invitrogen) was applied at a dilution of 1:20,000 in PBS for 5 min.
Images were acquired using a Zeiss LSM700 inverted confocalmicroscope
using 405- and 555-nm diode laser lines.
Statistical analysis. Fisher’s exact test was used to compare fecal bac-
terial shedding and incidence of diarrhea between experimental groups.
All other analyses were performed by using Student’s t test. A two-tailed P
value of	0.05 was taken to indicate statistical significance.
RESULTS
AfunctionalhomologofT2SSH10407 is conserved inEPEC.Com-
parison of the predicted sequences of the 13 components of the
T2SS of ETEC strain H10407 and EPEC strain E2348/69 revealed
a high degree of sequence conservation, with amino acid identity
ranging from 90.7 to 99.3%. To determine if this T2SS is func-
tional in EPEC, we established a cellular system to measure the
secretion of LTB, a nontoxic form of LT, which is the substrate of
this T2SS in ETEC. LTB, expressed from pJP33, was measured
with a GM1 ganglioside enzyme-linked immunosorbent assay
(ELISA) (61). The results showed that the wild-type strain, E2348/
69, secreted significantly more LTB into the culture medium than
an isogenic T2SS mutant, E2348/69gspD (P 	 0.005) (Fig. 1A)
(gspD encodes the outermembrane secretin that forms the pore of
the T2SS). In addition, LTB secretion was significantly restored in
FIG 1 EPEC strain E2348/69 requires a functional T2SS to secrete LTB and SslE into the culturemedium. (A) Concentration of LTB in the 5-hour CAYE culture
supernatant of wild-type E2348/69, an isogenic T2SS mutant, E2348/69gspD, and a trans-complemented mutant, E2348/69gspD(pJP52), containing an LTB
expression plasmid (pJP33) was measured by using GM1 ELISA. Values are the means (
SEM) of three independent experiments performed in triplicate (**, P
	 0.005). (B) SslE is secreted by the T2SS of EPEC strain E2348/69. SslE (arrow) was detected in the supernatant of wild-type strain E2348/69 (lane 1) and
trans-complementedmutants, E2348/69gspD(pJP52) (lane 3) and E2348/69gspK(pJP53) (lane 5), but not in the isogenic T2SSmutants, E2348/69gspD (lane
2) and E2348/69gspK (lane 4). Strains were grown in LB for 5 h. Proteins in the supernatants were precipitated with 10% trichloroacetic acid, washed in 25%
acetone, separated by SDS-PAGE using 4–12% bis-Tris NuPAGE gels (Invitrogen), and stained with Coomassie brilliant blue R-250. (C) SslE is not required for
the secretion of LTB. Concentration of LTB in the 5-hour CAYE supernatant of wild type, E2348/69, and its isogenic sslE mutant containing the pJP33
expression plasmid was measured by using GM1 ELISA. Values represent means (
SEM) of three independent experiments performed in triplicate.
The T2SS and SslE Are Virulence Determinants
June 2012 Volume 80 Number 6 iai.asm.org 2045
 o
n
 August 23, 2012 by DEAKIN UNIV
http://iai.asm
.org/
D
ow
nloaded from
 
a trans-complemented mutant, E2348/69gspD(pJP52) (P 	
0.005) (Fig. 1A).
SslE is a substrate of the EPEC T2SS. To determine the native
substrate(s) of the T2SS of EPEC, we compared the secretomes of
the wild-type strain and its isogenic gspD and gspK mutants. The
gspK gene encodes a subunit of the type II pseudopilus. Analysis of
the protein profiles revealed a high-molecular-weight protein of
approximately 170 kDa in the secretome of wild-type EPEC that
was absent from the secretome of the T2SSmutants (Fig. 1B). This
was excised and analyzed by using tandem mass spectrometry,
which identified this protein as YghJ, which is henceforth termed
SslE. Sequence analysis with Prosite (20) suggested that SslE is a
lipoprotein, with a strong prediction of a signal peptide (residues
1 to 23) and Cys24 predicted as being subject to covalentN-palmi-
toylation and the addition of S-diacylglycerol. Consistent with
this, LipoP 1.0 (35) predicted a Signal peptidase II cleavage site
(score 37.4) between residues 23 and 24. When SslE was puri-
fied from the extracellular medium and subjected to sequence
analysis by Edmandegradation, it was blocked, consistentwith the
acylation of the N-terminal Cys residue.
As SslE is part of the T2SSH10407 operon (67), we investigated if
SslE is a functional part of the secretion machinery. However, the
amount of LTB in the supernatant of the sslE mutant (E2348/
69sslE) was not significantly different (P  0.3) from that se-
creted by the wild type (Fig. 1C).
SslE is locatedon theouter cell surface.Thebest-studiedT2SS
is that ofKlebsiella pneumoniae, whose substrate is the lipoprotein
pullulanase, which becomes transiently anchored on the cell sur-
face before being released into the medium after the end of expo-
nential growth (37, 43). To determine if SslE behaves in a similar
manner, we constructed a plasmid, pJP169, where sslEwas tagged
at its C terminus with a tetracysteine tag and expressed from an
inducible tetA promoter. To establish conditions where the levels
of SslE-tetraCys in the cell were similar to those of SslE in the
wild-type strain, the expression of SslE-tetraCys was determined
in response to various amounts of the inducer, anhydrotetracy-
cline (Fig. 2A). SslE-tetraCys was visualized with Lumio Green by
using confocal microscopy, which showed that SslE is localized on
the bacterial cell surface (Fig. 2B). Treatment with proteinase K
removed the fluorescent signal, confirming that SslE was surface
located. In addition, incubation of E2348/69sslE(pJP169) with
proteinase K in the presence or absence of polymyxin B (which
selectively permeabilizes the outer membrane allowing access of
proteinase K to the periplasm [15]) revealed that SslE was cleaved
without polymyxin B (Fig. 2C). This result confirmed the outer
surface membrane location of SslE.
Cell envelope integrity in sslE and T2SS mutants.Mutations
in the T2SS of V. cholerae result in growth defects and compro-
mised outer membrane integrity, leading to defects in secretion
and induction of RpoE activity (RNA polymerase E) (60). This
was not the case in EPEC as comparison of the growth curves of
the E2348/69 wild type and the T2SSmutants showed that disrup-
tion of gspD or gspK had no effect on growth (see Fig. 4A). Growth
of an sslEmutant was also not impaired (Fig. 3A).
To assess if inactivation of the T2SS or SslE in E2348/69 led to
induction of a E-mediated stress response, we constructed and
used a micA-lacZ transcriptional fusion plasmid (pJP115) as a
reporter. In E. coli K-12, micA is transcribed from a single, E-
dependent promoter (64). As the sequence of micA of E2348/69,
including its promoter, is identical to that of E. coli K-12, the
activity of micA-lacZ provides a good measure of RpoE activity.
However, we found no increase in -galactosidase levels in the
E2348/69 T2SS or sslE mutants compared with the wild type, in-
dicating that thesemutations did not elicit a global stress response
(Fig. 3B).
SslE is required for biofilm formation byEPEC.Moreira et al.
(46) have proposed that the T2SS of EPEC might be involved in
the mature stage of biofilm development. After finding that the
T2SS played no part in the formation of biofilms in a static assay
(data not shown), we used confocal laser scanning microscopy to
examine the ability of E2348/69 and an isogenic T2SS mutant,
E2348/69gspD, to form biofilms in a continuous-culture flow
cell system. No obvious differences between the wild-type and
mutant biofilms were noted early during incubation; however, at
96 h clear differences were evident (Fig. 4A), with the T2SS mu-
FIG 2 SslE-tetraCys is located on the outer surface of the outer membrane of
EPEC strain E2348/69. (A) Titration of the inducer, anhydrotetracycline
(ATc), to determine the amount required to induce expression of sslE-tetraCys
to levels approximate to those of SslE in wild-type E2348/69. E2348/
69sslE(pJP169), where sslE-tetraCyswas expressed froma tetApromoter, was
grown in CAYE to an optical density at 600 nm (OD600) of 2 and then
induced for 2 h with 0, 30, 35, 40, or 50 ng/ml ATc (lanes 2 to 6, respectively).
Proteins were separated by SDS-PAGE using 4–12% bis-Tris NuPAGE gels
(Invitrogen) and stained with Coomassie brilliant blue R-250. (B) Fluorescent
and phase-contrast images of E2348/69sslE carrying plasmid pJP169
(pJP168::sslE-tetraCys) or the empty vector, pJP168, which was grown in
CAYE to an OD600 of2 and then induced for 2 h with 35 ng/ml anhydrotet-
racycline. Bacteria were visualized by differential interference phase contrast
on a Zeiss LSM700 inverted confocal microscope, and Lumio Green was ex-
cited using a 488-nm diode laser line. Bar, 2 m. (C) E2348/69sslE(pJP169)
cells were grown as described above and incubated without () or with ()
polymyxin B and proteinase K, as indicated. Proteins, separated by SDS-PAGE
using 4-12% bis-Tris NuPAGE gels (Invitrogen), were analyzed by Lumio
Green detection for SslE and by immunoblotting for the controls, BamA (in-
ner surface, outer membrane protein) and the cytoplasmicmembrane protein
FoF1 ATP synthase -subunit (F1). The latter served as a control for sample
loading, as it is protected from proteinase K by the inner membrane.
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tant, E2348/69gspD, showing sparse cell attachment to the sub-
stratum and the formation of small microcolonies. In compari-
son, both E2348/69 wild type and a trans-complemented T2SS
mutant, E2348/69gspD(pJP52), exhibitedmature-stage biofilms
with numerous largemicrocolonies and clearly visiblewater chan-
nels. Quantitative analysis of biofilm biomass indicated a signifi-
cant reduction in the mean biofilm biomass for the T2SS mutant,
E2348/69gspD, compared with the wild type (P	 0.0001) (Fig.
4B). Complementation of the gspD mutant with plasmid pJP52
restored mean biofilm biomass to wild-type levels. These results
showed that biofilm formation in the T2SS mutant is attenuated
and does not progress past the microcolony stage.
To determine if SslE is required for biofilm formation, we gen-
erated a plasmid expressing SslE (pJP15) and tested an E2348/69
isogenic mutant, E2348/69sslE, and a trans-complemented mu-
tant, E2348/69sslE(pJP15), in the continuous-culture flow cell
system. These analyses showed that the sslEmutant has defects in
biofilm maturation similar to those of the T2SS mutant, E2348/
69gspD (Fig. 4A and B).
SslE is a virulencedeterminantofEPEC.Rabbits infectedwith
REPEC, e.g., strain E22, show the same clinical and pathological
features as humans infected with EPEC (1, 42, 69). To ensure that
REPEC strain E22 was an appropriate proxy for EPEC strain
E2348/69, we constructed T2SS, sslE, and complemented mutant
strains of E22 and analyzed their protein secretion profiles and
ability to form biofilms. This analysis showed that SslE is a sub-
strate of the T2SS in E22 (Fig. 5A) and that the T2SS and SslE are
required for biofilm formation by this strain (Fig. 5B and C),
confirming a role for the T2SS and SslE in biofilm formation in
REPEC strains, as well as the human-specific strain E2348/69.
FIG 3 Analysis of growth and induction of the global stress response by T2SS and sslE mutants. (A) T2SS and sslE mutants do not display impaired growth.
Overnight cultures of wild-type E2348/69 and its isogenicmutants, E2348/69gspD, E2348/69gspK (T2SSmutants), and E2348/69sslE, were grown in LB and
diluted 1 in 100 in 10 ml LB in 50-ml Erlenmeyer flasks. (B) T2SS and sslE mutants do not induce RpoE activity. Mid-log-phase cultures (OD600, 0.7) of
wild-type E2348/69 and its isogenic mutants, E2348/69gspD, E2348/69gspK (T2SS mutants) and E2348/69sslE, containing the micA-lacZ transcriptional
fusion plasmid, pJP115, were grown in LB supplemented with trimethoprim and assayed for -galactosidase activity. Values represent means (
SEM) of three
independent experiments performed in quadruplicate.
FIG 4 Analysis of biofilm formation by EPEC E2348/69 and its derivatives. (A) Confocal laser scanning images of wild-type E2348/69 and its isogenic mutants,
E2348/69gspD (T2SS mutant) and E2348/69sslE, and trans-complemented mutants, E2348/69gspD(pJP52) and E2348/69sslE(pJP15). Shadow fluores-
cence projection images are rendered in Imaris. Bar, 50m. (B) Quantification of three-dimensional biofilm image stacks of wild-type E2348/69 and its isogenic
mutants, E2348/69gspD, and E2348/69sslE, trans-complemented mutants, E2348/69gspD(pJP52) and E2348/69sslE(pJP15), and these mutants comple-
mentedwith empty vector, E2348/69gspD(pACYC184) andE2348/69sslE(pSU39). T2SS and sslEmutants show significant defects in biofilm formation.Mean
biomass was calculated by using COMSTAT analysis (30) of at least eight random image stacks from each strain. Values represent the means (
SEM) of three
independent experiments expressed as a percentage of the wild type (***, P	 0.0001).
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FIG 5 Proteomic and biofilm analysis of REPEC E22 and its derivatives. (A) SslE is secreted by the T2SS of REPEC strain E22. SslE (arrow) was detected in the
supernatant of wild-type strain E22 (lane 1) and the trans-complemented mutants, E2348/69gspD(pJP51) (lane 3) and E2348/69gspK(pJP49), but not in the
isogenic T2SS mutants, E2348/69gspD (lane 2) and E2348/69gspK (lane 4). Strains were grown in LB for 5 h. Proteins in the supernatants were precipitated
in 10% trichloroacetic acid andwashed in 25%acetone. Proteins were separated by SDS-PAGEusing 4–12%bis-TrisNuPAGE gels (Invitrogen) and stainedwith
Coomassie brilliant blue R-250. (B) Confocal laser scanning images ofwild-type E22 and its isogenicmutants, E2348/69gspD, E2348/69gspK (T2SSmutants), and
E2348/69sslE, and the trans-complemented mutants, E2348/69gspD(pJP51), E2348/69gspK(pJP49), and E2348/69sslE(pJP16). Shadow fluorescence projection
images were rendered in Imaris. Bar, 50m. (C)Quantification of three-dimensional biofilm image stacks of wild-type E22 and its isogenicmutants, E2348/69gspD,
E2348/69gspK (T2SSmutants), andE2348/69sslE, thesemutants complementedwithemptyvector,E2348/69gspD(pACYC184),E2348/69gspK(pACYC184), and
E2348/69sslE(pSU39), and trans-complementedmutants, E2348/69gspD(pJP51), E2348/69gspK(pJP49), and E2348/69sslE(pJP16). T2SS and sslEmutants show
significant defects in biofilm formation. Mean biomass was calculated by using COMSTAT analysis of at least eight random image stacks from each strain. Values
represent means (
SEM) of three independent experiments expressed as a percentage of the wild type (***, P	 0.0005).
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To investigate the effect of the T2SS and SslE on the virulence
of EPEC, we infected infant rabbits with wild-type REPEC strain
E22 and isogenic T2SS and sslEmutants. Following inoculation of
7 rabbits with 106 CFU of wild-type E22, large numbers of REPEC
were shed in stools, such that 105 CFU were recovered from
rectal swabs from all rabbits within 3 days of inoculation. Loss of
body weight began within 48 h of infection and continued until
animals were euthanized (Fig. 6). All rabbits developed clinical
illness characterized by diarrhea with weight loss requiring eutha-
nasia. Five rabbits were euthanized onday 5, one on day 6, and one
on day 7 (Fig. 6). These results were consistent with previous re-
ports of infection of rabbits with E22 (42).
Following inoculation with 106 CFU of isogenic T2SS (gspK)
or sslE mutant strains, rabbits shed the challenge strain from the
second day after inoculation to 7 days postinoculation but yielded
lower bacterial counts in rectal swabs during the entire observa-
tion period (31/47 and 39/56 [days with counts of	103 CFU/days
of observation] for thegspK andsslE strains, respectively) com-
pared to 6/38 for rabbits infected with the wild-type strain (P 	
0.0001; Fisher’s exact test). One rabbit inoculated with the gspK
mutant began to lose weight on day 2, developed diarrhea on day
3, and was subsequently euthanized on day 5. Nevertheless, rab-
bits inoculated with eithermutant strain experienced significantly
fewer days of diarrhea (7/47 and 5/56 for the gspK and sslE
mutants, respectively) compared to rabbits infectedwith the wild-
type strain (17/38; P	 0.005).
Body weight is another sensitive indicator of illness in the
REPEC/rabbit infection model (1, 69), and during the course of
infection, rabbits infected with themutant strains showed normal
weight gain, in contrast to those infected with the wild type (Fig.
6). Taken together, these results indicated that the T2SS and its
substrate, SslE, are required for the virulence of REPEC strain E22.
Phenotype of sslE and T2SS mutants is independent of the
LEE. The major virulence factor of EPEC is its ability to produce
attaching and effacing lesions in the intestinal epithelium. These
are mediated by the products of the genes carried on the LEE. To
determine if the phenotypes we observed for the T2SS and sslE
mutants of EPEC were directly attributable to the inactivation of
these genes and not due to interplay with the LEE or known ad-
herence factors, such as bundle-forming pili, we examined the
ability of the T2SS and sslE mutants to elicit fluorescent actin
staining (FAS) and to adhere to cultured epithelial cells. FAS is a
well-established method to demonstrate the ability of EPEC to
evoke attaching and effacing lesions in vitro and is a marker of a
functional LEE (36). The results showed that the E2348/69 T2SS
and sslE mutants were FAS positive and displayed a localized ad-
herent wild-type phenotype. This indicates that the mutants were
not defective in adherence or in expression of the proteins en-
coded on the LEE (Fig. 7). These data were confirmed by electron
microscopic examination of ileal tissue from rabbits which
showed that the T2SS and sslEmutants of EPEC strain E22 caused
attaching and effacing lesions that were indistinguishable from
those elicited by the wild-type strain (Fig. 8).
DISCUSSION
In this study, we characterized a functional homolog of the
T2SSH10407 in EPEC. This T2SS is also present, and highly con-
served, in other E. coli pathotypes. Remnants of the T2SSH10407 are
also present in E. coli K-12 strains, which possess pppA-gspC and
the distal gspL-gspM genes but not the remainder of the operon.
Conservation of the entire operon for T2SSH10407 in pathogenic
varieties of E. coli suggests that this system performs an essential
function: not for planktonic growth, but for pathogenesis. In
ETEC, the T2SSH10407 is essential for the secretion of LT, but EPEC
and other E. coli pathotypes do not possess LT, suggesting that the
T2SSH10407 homologs in these bacteria have alternate substrates.
A proteomics approach revealed that SslE is a major substrate
secreted by the T2SS of EPEC strain E2348/69. Use of an LTB
reporter, however, demonstrated that this T2SS is capable of se-
creting other substrates, and we do not rule out that EPEC and
FIG 6 Effect of infection with REPEC strain E22 or its isogenic derivatives on
weight gain by infant rabbits. Values are the mean (
SD) weight for each
group expressed as a percentage of the weight on the day of infection (day
zero). Eight rabbits were inoculated with 106 CFU wild-type E22, and seven
rabbits were inoculated with 106 CFU of either the T2SS (gspK) or the sslE
mutant. When some rabbits in a group were euthanized, due to a body weight
loss of greater than 15% or severe diarrhea, the surviving numbers of rabbits
are shown adjacent to the data points.
FIG 7 Effect of mutations in the T2SS or SslE of E2348/69 on attaching and effacing lesion formation and adherence to HEp-2 cells visualized by using
fluorescence actin staining (FAS) and nucleic acid staining, respectively. Representative fluorescent images of HEp-2 cells incubated for 3 h with wild-type
E2348/69 or its isogenic mutants, E2348/69gspD, E2348/69gspK (T2SS mutants), and E2348/69sslE, showing the bacteria (blue) adhering to HEp-2 cells
(faint red with blue nucleus) in a pattern of localized adherence and FAS-positive lesions (bright red and arrowed) associated with the adherent bacteria. Actin
was stained with TRITC-conjugated phalloidin, and bacterial and HEp-2 cell DNA was stained with DAPI. Bar, 10 m.
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other pathotypes of E. colimay secrete other proteins via the T2SS.
Nevertheless, several lines of evidence point to SslE as the domi-
nant substrate. First, the sslE gene is located immediately upstream
of all sequenced T2SSH10407 operons. We reported previously that
the gspCDEFGHIJKLM cluster and three other upstream genes,
sslE (yghJ), pppA, and yghG, are cotranscribed and that the pro-
moter of sslE plays a major role in the expression of this 14-gene
transcriptional unit (67). Thus, activation of substrate (SslE) ex-
pression is coordinated with expression of the entire T2SS. Sec-
ond, sslE mutants failed to develop as biofilms and showed a re-
duced ability to colonize the intestine and cause disease in a rabbit
model of infection, thus phenocopying type II secretion mutants.
Although the biochemical function of SslE is yet to be deter-
mined, this work has established its link to EPEC pathogenesis.
Accessory colonization factor D (AcfD), encoded byV. cholerae, is
an ortholog of SslE, and we predict that this protein too will be a
substrate of the T2SS. Importantly, AcfD also appears to be re-
quired for efficient colonization of infant mouse intestine (50).
UnlikeV. choleraewheremutations in the T2SS result inmem-
brane perturbation and induction of a E-mediated stress re-
sponse (60), our T2SS EPEC mutants showed no signs of growth
defects orE induction, indicating that the attenuated biofilm and
virulence phenotypes are not due to diminished bacterial fitness
but are caused by the absence of a type II secreted protein(s),
specifically SslE.
We also showed that SslE is translocated across the outermem-
brane via the T2SS and becomes anchored on the cell surface, thus
extending the finding of Moriel et al. (47), who used flow cyto-
metry to detect SslE on the surface of an ExPEC strain isolated
froma case of neonatalmeningitis. The presence of SslE on the cell
surface may be important for cell-to-cell or cell-to-surface inter-
actions, which would explain why SslE expression is required for
biofilm formation.
Although previously characterized adhesins have been impli-
cated in EPEC biofilms, they contribute to the early stages of bio-
film formation. Specifically, type I fimbriae are involved in attach-
ment to the surface of flow cells; also, the LEE-encoded adhesin
EspA and the bundle-forming pili of E2348/69 are required for the
formation of small microcolonies (46). However, attachment and
small microcolony formation are unaffected in T2SS and sslEmu-
tants, demonstrating that the T2SS and SslE are required for bio-
filmmaturation. The involvement of biofilms in EPEC pathogen-
esis is novel, but not entirely unexpected, as biofilms have been
implicated in the pathogenesis of other E. coli pathotypes such as
ExPEC (3, 4) and EAEC (45).
The main virulence determinant of EPEC is the LEE; however,
inactivation of the T2SS did not affect expression of the LEE pro-
teins. Consequently, the reduced ability of SslE and T2SSmutants
of REPEC to cause disease in rabbits may be explained by the
inability of these mutants to produce mature biofilms. Biofilm
bacteria are resistant to host defenses, as aggregation into biofilms
protects them from mechanical removal and phagocytosis and
reduces their accessibility to the humoral immune system (16, 17,
27, 28). Consequently, wild-type bacteria may be able to persist
due to the formation of mature biofilms, whereas the T2SS and
sslE mutants are accessible to immune defenses and are cleared.
Interestingly, a recent subtractive reverse vaccinology study se-
lected SslE as one of nine protective antigens in a sepsis mouse
challenge model. Active immunization of mice with SslE from
ExPEC strain IHE3034 gave 82% protection against systemic in-
fection with the homologous strain, and passive immunization
with an SslE antiserum showed almost complete protection
against systemic infection, indicating that SslE may be an attrac-
tive vaccine target (47).
In conclusion, we have shown that the T2SSH10407 is an im-
portant virulence determinant of EPEC. We demonstrated that
the T2SS and its substrate, SslE, are essential for the virulence
of EPEC for rabbits and that the T2SS and SslE are also required
for the formation of mature biofilms, thus suggesting a role for
biofilm formation in EPEC pathogenesis. More importantly, as
this T2SS and SslE are both highly conserved, they may also
play a role in biofilm formation by other E. coli pathotypes,
such as ExPEC and EAEC, where biofilm formation is also re-
quired for virulence.
FIG 8 Transmission electron micrographs of sections of rabbit ileum 7 days
after inoculation with E. coli E22 (wild type) (A), an isogenic T2SS (gspK)
mutant (B), or an isogenic sslE mutant (C). Note the characteristic attaching
and effacing lesions caused by all three strains. Original magnification,
14,000.
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